Mayzent28 (Siponimod Tablet) 2mg

MAYZENT28 (Siponimod 2mg) is an oral tablet used for relapsing forms of multiple sclerosis. Store between 2-8°C and protect from light. Consult a healthcare provider for suitability. Short-term supply for ongoing therapy.

Strength

2mg

Pack Size

28s

Storage

2-8°

Manufacturer / TM Owner

Novartis pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Siponimod 2mg tablets are prescribed to reduce relapses and delay disability progression in adults with relapsing forms of multiple sclerosis (RMS). It is also used for clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. Patients often ask what is Siponimod used for and whether it can help with MS symptoms.

Side Effects

This medication works by affecting the immune system to reduce inflammation in the central nervous system. Users may notice fewer MS flare-ups over time. Some report improved mobility or reduced fatigue, though individual responses vary. Regular monitoring is advised during treatment.

Precautions & Warnings

Keep MAYZENT28 refrigerated between 2–8°C and protect from light. Do not use if the package is damaged or the seal is broken. Inform your doctor about all current medications and medical history before starting treatment. Avoid sudden discontinuation without medical guidance.

Avoid Interactions

Siponimod may interact with strong CYP2C9 inhibitors, certain antidepressants, and heart medications. Grapefruit products can affect how the drug is processed. Alcohol use should be discussed with a healthcare provider. Always review all prescriptions and over-the-counter products with your pharmacist.

Frequently Asked Questions

It is used to treat relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome and active secondary progressive MS.

Store the tablets refrigerated between 2–8°C and protect them from light. Do not freeze.

It may interact with several drugs. Always inform your doctor or pharmacist about all medications you are taking before starting Siponimod.

Contact your healthcare provider for guidance if a dose is missed. Do not take two doses at once.

The safety of Siponimod during pregnancy has not been established. Discuss risks and alternatives with your doctor if you are pregnant or planning pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.